NCT01034306View on ClinicalTrials.gov

Oral CF101 Tablets Treatment in Patients With Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Rheumatoid Arthritis
Interventions
DRUG

CF101

orally q12h

DRUG

Placebo control

orally q12 hours

Trial Locations (5)

1359

Multiprofile Hospital for Active Treatment, Sofia

1505

Diagnostic Consultative Center Sofia, Sofia

1606

Military Medical Academy, Sofia

1612

"UMHAT Sveti Ivan Rilski, Rheumatoloty Clinic", Sofia

Unknown

Barzilai Medical Center, Ashkelon

Sponsors

Lead Sponsor

Can-Fite BioPharma
All Listed Sponsors
lead

Can-Fite BioPharma

INDUSTRY